Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE26.6200
- TODAY'S CHANGE (%)-0.2300 (-0.8566%)
- Bid / Lots26.5300/ 1
- Ask / Lots26.9200/ 1
- Open / Previous Close26.7900 / 26.8500
- Day Range
- 52 Week Range
- Volume1,727,314
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 23719 | 26.89 |
| 09:34 ET | 1537 | 26.77 |
| 09:36 ET | 6458 | 26.71 |
| 09:38 ET | 2959 | 26.84 |
| 09:39 ET | 1707 | 26.81 |
| 09:41 ET | 3542 | 26.8 |
| 09:43 ET | 3542 | 26.705 |
| 09:45 ET | 10577 | 26.62 |
| 09:48 ET | 11378 | 26.6 |
| 09:50 ET | 7196 | 26.63 |
| 09:52 ET | 5185 | 26.555 |
| 09:54 ET | 4874 | 26.575 |
| 09:56 ET | 4989 | 26.61 |
| 09:57 ET | 2648 | 26.585 |
| 09:59 ET | 4523 | 26.59 |
| 10:01 ET | 3359 | 26.58 |
| 10:03 ET | 6971 | 26.65 |
| 10:06 ET | 2913 | 26.625 |
| 10:08 ET | 4132 | 26.595 |
| 10:10 ET | 7957 | 26.585 |
| 10:12 ET | 2381 | 26.595 |
| 10:14 ET | 13146 | 26.585 |
| 10:15 ET | 5762 | 26.58 |
| 10:17 ET | 4821 | 26.54 |
| 10:19 ET | 2699 | 26.5499 |
| 10:21 ET | 2337 | 26.5205 |
| 10:24 ET | 2441 | 26.535 |
| 10:26 ET | 12818 | 26.56 |
| 10:28 ET | 5626 | 26.57 |
| 10:30 ET | 2760 | 26.54 |
| 10:32 ET | 3085 | 26.53 |
| 10:33 ET | 15773 | 26.54 |
| 10:35 ET | 3435 | 26.56 |
| 10:37 ET | 1906 | 26.5705 |
| 10:39 ET | 2800 | 26.575 |
| 10:42 ET | 2862 | 26.565 |
| 10:44 ET | 4117 | 26.545 |
| 10:46 ET | 4424 | 26.54 |
| 10:48 ET | 2693 | 26.53 |
| 10:50 ET | 8476 | 26.515 |
| 10:51 ET | 7146 | 26.4995 |
| 10:53 ET | 3765 | 26.55 |
| 10:55 ET | 19457 | 26.555 |
| 10:57 ET | 6443 | 26.57 |
| 11:00 ET | 1483 | 26.5599 |
| 11:02 ET | 7203 | 26.555 |
| 11:04 ET | 2300 | 26.62 |
| 11:06 ET | 3110 | 26.61 |
| 11:08 ET | 1454 | 26.595 |
| 11:09 ET | 4991 | 26.58 |
| 11:11 ET | 3882 | 26.615 |
| 11:13 ET | 2254 | 26.61 |
| 11:15 ET | 2903 | 26.66 |
| 11:18 ET | 3836 | 26.67 |
| 11:20 ET | 9177 | 26.665 |
| 11:22 ET | 5480 | 26.67 |
| 11:24 ET | 2131 | 26.65 |
| 11:26 ET | 7176 | 26.635 |
| 11:27 ET | 17931 | 26.66 |
| 11:29 ET | 1594 | 26.65 |
| 11:31 ET | 1500 | 26.66 |
| 11:33 ET | 2169 | 26.66 |
| 11:36 ET | 5049 | 26.635 |
| 11:38 ET | 1100 | 26.635 |
| 11:40 ET | 1679 | 26.635 |
| 11:42 ET | 3035 | 26.645 |
| 11:44 ET | 2092 | 26.65 |
| 11:45 ET | 2784 | 26.64 |
| 11:47 ET | 2577 | 26.64 |
| 11:49 ET | 2774 | 26.665 |
| 11:51 ET | 2612 | 26.65 |
| 11:54 ET | 2631 | 26.64 |
| 11:56 ET | 3370 | 26.655 |
| 11:58 ET | 1233 | 26.665 |
| 12:00 ET | 2382 | 26.655 |
| 12:02 ET | 10688 | 26.635 |
| 12:03 ET | 6376 | 26.66 |
| 12:05 ET | 2853 | 26.66 |
| 12:07 ET | 1800 | 26.675 |
| 12:09 ET | 200 | 26.665 |
| 12:12 ET | 1966 | 26.67 |
| 12:14 ET | 2965 | 26.65 |
| 12:16 ET | 2285 | 26.63 |
| 12:18 ET | 1547 | 26.635 |
| 12:20 ET | 3916 | 26.625 |
| 12:21 ET | 6244 | 26.62 |
| 12:23 ET | 2625 | 26.65 |
| 12:25 ET | 2000 | 26.64 |
| 12:27 ET | 2371 | 26.655 |
| 12:30 ET | 2060 | 26.66 |
| 12:32 ET | 6624 | 26.66 |
| 12:34 ET | 2300 | 26.645 |
| 12:36 ET | 6614 | 26.625 |
| 12:38 ET | 1100 | 26.62 |
| 12:39 ET | 6753 | 26.61 |
| 12:41 ET | 2651 | 26.595 |
| 12:43 ET | 1508 | 26.585 |
| 12:45 ET | 3773 | 26.571 |
| 12:48 ET | 5681 | 26.605 |
| 12:50 ET | 2428 | 26.595 |
| 12:52 ET | 4884 | 26.61 |
| 12:54 ET | 2663 | 26.62 |
| 12:56 ET | 3938 | 26.6 |
| 12:57 ET | 1522 | 26.605 |
| 12:59 ET | 3803 | 26.59 |
| 01:01 ET | 9284 | 26.595 |
| 01:03 ET | 4521 | 26.63 |
| 01:06 ET | 121663 | 26.49 |
| 01:08 ET | 11954 | 26.525 |
| 01:10 ET | 10214 | 26.575 |
| 01:12 ET | 4722 | 26.59 |
| 01:14 ET | 4481 | 26.58 |
| 01:15 ET | 420 | 26.59 |
| 01:17 ET | 7898 | 26.595 |
| 01:19 ET | 9482 | 26.605 |
| 01:21 ET | 6493 | 26.59 |
| 01:24 ET | 13659 | 26.595 |
| 01:26 ET | 4102 | 26.555 |
| 01:28 ET | 2050 | 26.53 |
| 01:30 ET | 5521 | 26.54 |
| 01:32 ET | 3334 | 26.59 |
| 01:33 ET | 1343 | 26.585 |
| 01:35 ET | 3308 | 26.6 |
| 01:37 ET | 3224 | 26.6092 |
| 01:39 ET | 3624 | 26.615 |
| 01:42 ET | 1440 | 26.6147 |
| 01:44 ET | 6210 | 26.605 |
| 01:46 ET | 1552 | 26.6 |
| 01:48 ET | 4195 | 26.64 |
| 01:50 ET | 3834 | 26.645 |
| 01:51 ET | 7258 | 26.655 |
| 01:53 ET | 8110 | 26.615 |
| 01:55 ET | 7284 | 26.605 |
| 01:57 ET | 4577 | 26.62 |
| 02:00 ET | 2164 | 26.59 |
| 02:02 ET | 600 | 26.585 |
| 02:04 ET | 6171 | 26.585 |
| 02:06 ET | 4399 | 26.57 |
| 02:08 ET | 4132 | 26.575 |
| 02:09 ET | 12897 | 26.575 |
| 02:11 ET | 1735 | 26.56 |
| 02:13 ET | 5229 | 26.61 |
| 02:15 ET | 989 | 26.62 |
| 02:18 ET | 10001 | 26.58 |
| 02:20 ET | 2571 | 26.575 |
| 02:22 ET | 1000 | 26.565 |
| 02:24 ET | 5580 | 26.555 |
| 02:26 ET | 2354 | 26.55 |
| 02:27 ET | 1000 | 26.55 |
| 02:29 ET | 1804 | 26.55 |
| 02:31 ET | 2600 | 26.55 |
| 02:33 ET | 7362 | 26.545 |
| 02:36 ET | 2763 | 26.555 |
| 02:38 ET | 500 | 26.555 |
| 02:40 ET | 7156 | 26.565 |
| 02:42 ET | 1389 | 26.565 |
| 02:44 ET | 2616 | 26.575 |
| 02:45 ET | 6482 | 26.565 |
| 02:47 ET | 1835 | 26.565 |
| 02:49 ET | 4531 | 26.565 |
| 02:51 ET | 3017 | 26.555 |
| 02:54 ET | 2380 | 26.547 |
| 02:56 ET | 7306 | 26.545 |
| 02:58 ET | 3400 | 26.555 |
| 03:00 ET | 3050 | 26.54 |
| 03:02 ET | 3897 | 26.555 |
| 03:03 ET | 7099 | 26.545 |
| 03:05 ET | 3243 | 26.545 |
| 03:07 ET | 8583 | 26.555 |
| 03:09 ET | 11062 | 26.585 |
| 03:12 ET | 7445 | 26.59 |
| 03:14 ET | 3654 | 26.585 |
| 03:16 ET | 4155 | 26.575 |
| 03:18 ET | 2879 | 26.565 |
| 03:20 ET | 6550 | 26.585 |
| 03:21 ET | 7021 | 26.57 |
| 03:23 ET | 6940 | 26.565 |
| 03:25 ET | 5427 | 26.565 |
| 03:27 ET | 3373 | 26.57 |
| 03:30 ET | 3102 | 26.575 |
| 03:32 ET | 6491 | 26.585 |
| 03:34 ET | 2682 | 26.5859 |
| 03:36 ET | 12766 | 26.59 |
| 03:38 ET | 1516 | 26.585 |
| 03:39 ET | 4100 | 26.58 |
| 03:41 ET | 10781 | 26.57 |
| 03:43 ET | 5052 | 26.555 |
| 03:45 ET | 7640 | 26.555 |
| 03:48 ET | 5669 | 26.54 |
| 03:50 ET | 6867 | 26.55 |
| 03:52 ET | 12987 | 26.575 |
| 03:54 ET | 7629 | 26.575 |
| 03:56 ET | 27856 | 26.61 |
| 03:57 ET | 22927 | 26.6 |
| 03:59 ET | 56604 | 26.62 |
May 22, 2024
DJ Cytokinetics Falls 10% on Royalty Pharma Transaction, Stock Offer, from 4:35PM ET on Wednesday May 22, 2024 by Dow Jones
4:35PM ET on Wednesday May 22, 2024 by Dow JonesRoyalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline, from 4:10PM ET on Wednesday May 22, 2024 by Dow Jones
4:10PM ET on Wednesday May 22, 2024 by Dow JonesCytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline, from 4:00PM ET on Wednesday May 22, 2024 by Dow Jones
4:00PM ET on Wednesday May 22, 2024 by Dow Jones
May 17, 2024
DJ S&P 500 Futures Steady In Premarket Trading; RBC Bearings, GameStop Lag, from 7:31AM ET on Friday May 17, 2024 by Dow Jones
7:31AM ET on Friday May 17, 2024 by Dow Jones
May 13, 2024
Royalty Pharma to Present at Upcoming Investor Conferences, from 8:15AM ET on Monday May 13, 2024 by Dow Jones
8:15AM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.0B | 14.9x | +1.83% |
Amneal Pharmaceuticals Inc | 2.0B | -11.4x | --- |
Catalent Inc | 9.9B | -8.5x | --- |
Jazz Pharmaceuticals PLC | 6.6B | 21.9x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.2B | 15.3x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.0B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.16% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 14.9x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 13.5x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
